NCT06334432: An ongoing trial by Nuvation Bio, Inc.
This trial is ongoing. It must report results 2 years, 7 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06334432 |
|---|---|
| Title | A Phase 1/2, First-in-Human, Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | March 14, 2024 |
| Completion date | March 31, 2027 |
| Required reporting date | March 31, 2028, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Sept. 2, 2025 |
| Days late | None |